chemotherapy - search results

For patients battling glioblastoma, a highly aggressive and deadly form of brain cancer, resistance to chemotherapy remains a significant obstacle.

NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.

Damaged heart muscle is a tragic possibility for patients of breast cancer chemotherapy - but thanks to Dr Husam Abdel-Qadir, there may now be a way to stop it.

Boston Medical Center researchers found that Black individuals, above all other racial groups, are less likely to receive lung cancer chemotherapy.

Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

A biomarker is a measurable substance, typically a chemical or biomolecule (protein, lipid, nucleic acid), found in biological samples that is indicative of a normal or abnormal condition of a living organism. But how can biomarkers be used in deciphering human health impacts of environmental contaminants?

Inhealthcare is working with one of the UK’s largest teaching hospital trusts to develop the next generation of virtual wards. Natalie Duffield, sales and marketing director, explains how the company is helping to improve patient experience and reduce pressure on NHS beds.

Dr Mark Verrill, Consultant Medical Oncologist at the Northern Centre for Cancer Care, discusses the importance of personalised breast cancer treatment.

Long waits for cancer care have become normal across the UK, with nearly half of all specialist cancer centres experiencing delays most weeks, according to the Royal College of Radiologists (RCR).

Zisis Kozlakidis from the World Health Organization’s International Agency for Cancer and Jiaao Yu from the Shanghai Jiao Tong University discuss the burden of lung cancer in Southeast Asia and China and the priorities for therapies and interventions.

Lance R. McMahon, Ph.D. and Jenny L. Wilkerson, Ph.D. from Texas Tech University Health Sciences Center, describe the search for the magic bullet to treat both neuropathic pain and nicotine dependence using novel epibatidine derivatives as potential therapeutics.

Venous catheters enable patients with haematological cancers to receive vital chemotherapy. However, there is a risk of thrombosis. Consultant Haematologist Priya Sriskandarajah analysed a group of patients with haematological cancers to study the implications of catheter selection.

Nanotextures on nanoparticles and implants to kill cancer cells in a more targeted manner may just be the key to tackling resistance to traditional cancer drugs.

Peter J. Houghton from Greehey Children’s Cancer Research Institute and Mary-Ann Bjornsti from the University of Alabama discuss some of the key challenges in the development of therapies for pediatric cancer care.

Using artificial intelligence, scientists have tackled one of the toughest challenges in cancer research.

Starting in January 2020, the European REVERT project is now in its final phase. The project blends predictive medicine and AI to enable clinicians to quickly and adequately treat patients.

Current oncology treatments have significantly improved cancer survival rates, but more effective and safer therapeutics are needed.

Simon Holt, Honorary Professor at Swansea University, reflects on the key challenges within cancer care and the benefits of genomic testing in improving patient outcomes.

NHS trusts are exploring new opportunities to use infrastructure that they already own. The aim? To better engage with patients, alleviate their anxieties, and inform patients what is happening regarding their care, whilst at the same time reducing pressures on busy wards. Matt O’Donovan, Chief Executive at SPARK TSL, explains.